CherylCho-PhanMD

Oncology • Stanford, CA

Clinical Assistant Professor, Medicine - Oncology, Stanford University Medical Center

Join to view full profile

Are you Dr. Cho-Phan?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 68 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
875 Blake Wilbur Dr
# Stanford
Stanford, CA 94304
Phone+1 650-498-6000

Summary

Dr. Cheryl Cho-Phan, MD is an oncologist in Stanford, California. She is currently licensed to practice medicine in California and Oregon. She is affiliated with Stanford Health Care and is a Clinical Assistant Professor at Stanford University Medical Center.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1999 - 2002
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1996 - 1999
Georgetown University School of MedicineClass of 1996

Certifications & Licensure

OR State Medical License 1997 - Present
CA State Medical License 1999 - 2025

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies Start of enrollment: 2010 Sep 01
Terminated
Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy Start of enrollment: 2011 Jul 01
Completed
Phase 3

Publications & Presentations

PubMed

1 citations
Understanding Racial and Ethnic Inequities in Uptake and Outcomes Following Multigene Prognostic Testing in Early Breast Cancer: The Promise of Real-World Data.
Xiaoliang Wang, Cheryl D Cho-Phan, Kent F Hoskins, Gregory S Calip
Cancer Epidemiology, Biomarkers & Prevention. 2022-04-01
7 citations
Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma.
Liangliang Zhang, Omar Hamdani, Ole Gjoerup, Cheryl Cho-Phan, Jeremy Snider
JCO Precision Oncology. 2022-01-01
5 citations
RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer
Alexa B. Schrock, J. Lee, Jaideep Sandhu, Russell Madison, Cheryl D. Cho-Phan
The Oncologist. 2021-06-01